Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn’s Disease

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn’s Disease

OBJECTIVES: The aim of this study was to evaluate the quantitative serum level of infliximab (IFX) as well as the detection of anti-infliximab antibodies (ATIs) in patients with Crohn’s disease (CD). METHOD: Forty patients with CD under treatment at a tertiary center in southeastern Brazil were eva...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Luis Eduardo Miani Gomes, Francesca Aparecida Ramos da Silva, Lívia Bitencourt Pascoal, Renato Lazarin Ricci, Guilherme Nogueira, Michel Gardere Camargo, Maria de Lourdes Setsuko Ayrizono, João José Fagundes, Raquel Franco Leal
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Elsevier España 2019-04-01
Seri Bilgileri:Clinics
Konular:
Crohn’s Disease
Infliximab
Antibody
Drug Monitoring
Online Erişim:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322019000100216&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322019000100216&lng=en&tlng=en

Benzer Materyaller